NYSE:WATLife Sciences
Waters (WAT) Is Up 5.1% After Raising 2026 Revenue Guidance Amid Integration Progress – What’s Changed
In early August 2026, Waters Corporation reported second-quarter results showing sales of US$1.65 billion versus US$771 million a year earlier, alongside a shift from net income of US$147 million to a net loss of US$136 million, and issued third-quarter and full-year 2026 revenue guidance of US$1.75–1.76 billion and US$6.42–6.48 billion respectively.
Management highlighted 9% organic constant currency growth, strong performance in pharmaceutical and academic markets, faster growth in newly...